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Abstract
Background: Pseudoexfoliation syndrome (PXS) is the most common identifiable cause of
secondary glaucoma, the prevalence of which varies considerably among different ethnicities. The
aim of this study was to assess the prevalence of pseudoexfoliation syndrome in Pakistan.
Methods: A prospective study conducted in the period from January 2003 to June 2004 in a
teaching hospital serving a population of about 7.6 million. 1860 patients aged 45 or above attending
the general ophthalmic clinics were recruited for this study. A detailed evaluation including
ophthalmic and general history, slit lamp biomicroscopy, intraocular pressure measurement,
gonioscopy and dilated eye examination was performed on all patients.
Results: 120(6.45%) subjects were found to have PXS with a male to female ratio of 1.5:1. All 120
(100%) cases were bilateral and 48(40%) patients had high intraocular pressure.
Conclusion: To the best of our knowledge, this is the first study conducted in a Pakistani
population to determine the prevalence of PXS. The prevalence rate of 6.45% is similar to other
studies conducted in south Asia, however all cases were bilateral and quite a high percentage of
patients had high intra-ocular pressure.
Background
Pseudoexfoliation syndrome (PXS) is characterized by the
deposition of a distinctive fibrillar material in the anterior
segment of the eye and was first described in 1917 by
Lindberg [1]. It is frequently associated with open angle
glaucoma, known as pseudoexfoliation glaucoma, which
is the most common identifiable form of secondary open
angle glaucoma worldwide [2]. Despite extensive
research, the exact chemical nature of the fibrillar material
is unknown. It is believed to be secreted multifocally in
the iris pigment epithelium, the ciliary epithelium, and
the peripheral anterior lens epithelium [3]. The material
moves into the aqueous humor and is carried to the
trabecular meshwork, following the normal flow.
Obstruction of the trabecular meshwork by this fibrillar
material and pigment causes elevation of the intraocular
pressure (IOP) leading to glaucoma [4].
PXS is now suspected to be a systemic disorder and has
been associated preliminarily with stroke, systemic hyper-
tension, and myocardial infarction [5]. In fact pseudoex-
foliative like material has been found in lungs, skin, liver,
heart, kidney, gallbladder, blood vessels, extra ocular
muscles and meninges [6].
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increases markedly with age [7]. Although it occurs in vir-
tually every area of the world, a considerable racial varia-
tion exists. In the Framingham study, prevalence of PXS
was found to be1.8% [8]. In another study of subjects over
60 years in various ethnicities, prevalence rates ranging
from 0% in Greenland Eskimos to 21% in Icelanders were
noted [9]. In northern/western European countries
including England, Germany, and Norway prevalence of
4.0%, 4.7%, and 6.3% have been reported respectively
[10].
Although epidemiological studies of PXS have been done
in South Asia [11,12], but there is no data available on
prevalence of PXS in Pakistan. This study was performed
to determine the prevalence of PXS in Pakistan.
Methods
After approval from Hospital Ethics Committee, cross-sec-
tional hospital based study was performed at Bahawalpur
Victoria Hospital, (BVH) Bahawalpur, Pakistan. BVH is a
regional tertiary care centre and university hospital of
Bahawalpur division that serves a population of
7,635,591 people. (PopulationCensus Organization
1998-census, Government of Pakistan) All the patients
who were 45 years of age or older presenting to eye out
patient department from January 2003 to June 2004 were
asked to enrol for this study. After informed consent the
patients underwent complete ophthalmic evaluation. This
included complete ophthalmic and general history, best
corrected visual acuity, slit lamp examination, applana-
tion tonometry and gonioscopy. The patients were then
dilated and slit lamp examination of the lens and fundus
was carried out. The patients who were found to have nar-
row or occludable angles on gonioscopy were first offered
laser iridotomy treatment. The rest of the evaluation was
then deferred to a later date. An angle was considered
occludable if the pigmented trabecular meshwork was not
visible in 180 o or more of the angle. For IOP measure-
ment, only the higher IOP between the two eyes was con-
sidered. Any IOP of more than 22 mm Hg was considered
as high and only if the pressure was again high after 10
minutes of wait and tested by a second examiner on a dif-
ferent slit lamp. The criterion used to diagnose PXS was
the presence of pseudoexfoliation material on one or
more anterior segment structures. Since the presence of
pseudoexfoliative material on lens is the most consistent
and prominent feature of PXS, so to prevent under estima-
tion of the prevalence, all subjects who were psuedopha-
kic or aphakic in any eye were excluded from the study.
Also noted were demographic details, reason of attend-
ance and presence of any systemic disease. Since the aim
of the study was prevalence of PXS in a given population
so no attempt was made to determine the prevalence or
incidence of glaucoma in PXS patients.
Statistical analysis was performed using Statistical Package
for Social Sciences (SPSS version 12.0, Chicago IL). Chi
square test was used to compare discrete variables and
Mann Whitney test was used to compare ordinal data.
Results
1860 patients were recruited for the study. There were
1040 males and 820 female with a male female ratio of
1.27:1. Demographic details and the reason of attendance
to the eye clinic are shown in Table 1. The stratification of
age is shown in Table 2.
120 patients were found to be having PXS with an overall
prevalence of 6.45%. The salient clinical features of the
Table 1: Demographic details and reason of attendance to the eye clinic
All Patients n = (1860) Patients with PXS N = (120)
Age in years 45–87 (63.6) 51–84 (72.2)
Male to Female ratio 1.2–1 1.5–1
Mean Vision 6/18 6/12
Prevalence of diabetes 10.2% 10.8%
Prevalence of high blood pressure 13.4% 16.6%
Reason of Attendance
Cataract 32.3% 52.5%
Ocular surface/lid disorders 23.7% 8.3%
Age related macular degeneration 11.3% 15.0%
Diabetic retinopathy 8.6% 5.0%
Glaucoma 8.2% 12.5%
Uveitis 3.0% 0.0%
Retinal vascular diseases 3.0% 5.0%
Neurophthalmological Problems 2.9% 0.8%
Hereditery Retinal diseases 1.7% 0.0%
History of Infectious corneal ulcers 1.3% 0.8%
Others 4.1% 0.0%Page 2 of 5
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bilateral though asymmetrical. The mean age of patients
with PXS was 72.2 years, which was significantly higher
compared to 63.6 in whole examined population (p <
0.0001)
There were 72 males and 48 females with a male to female
ratio of 1.5:1. The prevalence of PXS was 6.92% in males
and 5.8% in females and this difference was not signifi-
cant. The prevalence of PXS increased with the increasing
age as shown in Table 4.
As shown in table 4, 75% of the patients with PXS were 70
years old or above. The prevalence was 2.6% in patients
less than 70 years of age, which increased to 13.04% in
patients 70 years old or older. (p = 0.001). High IOP
(more than 22) was noted in 48 patients (40%). It was
also noted that prevalence of high IOP increased with
increasing age. The mean age of patient with PXS and high
IOP (n = 48) was 74.2 years compared to 71 years in
patients with normal IOP (n = 72) p = 0.02. Occludable
angles were seen in 5 patients (4.1%) with PXS compared
to 40 patients (2.29%) with out PXS. Although the
occludable angles were more common in patients with
PXS but the difference was not statistically significant and
this difference could also be attributed to the age which
was significantly higher in PXS group.
Discussion
The reported prevalence rate of PXS syndrome in different
populations shows extensive variations, 0% in Eskimos
[9], 1.8% in the United States [8], 5–25 % in the Scandi-
navian countries [9], and 38% in Navajo Indians [13].
This variation is combination of true differences due to
racial difference, the age and sex distribution of the popu-
lation group examined, the criteria used to define exam-
ined populations that is, persons over a certain age,
patients taken from eye clinics, patients with cataracts,
and glaucoma patients. The prevalence of PXS increases
progressively among the following groups: 1) the general
population; 2) persons over age 50; 3) ocular hyperten-
sives; 4) glaucoma patients; 5) glaucoma patients admit-
ted to the hospital.
This study is first study of its kind from Pakistan. Our
examined population was recruited from the eye clinic
and we found the prevalence to be 6.45%. This is quite
similar to 7.4% in a similar hospital based study from
India [14] and 6% in south Indian population based sur-
vey [15] and slightly lower than in neighboring Iran where
the prevalence was found to be 9.6% [16]. These geo-
graphic distribution patterns may perhaps be explained
either by regional gene pools or by environmental influ-
ences. However it should be noted that prevalence in our
study was significantly higher from two large epidemio-
logical studies from South India [11,12] and it could be
attributed to design of the study which was different in
our study.
We did not notice any sex predilection; however the prev-
alence was slightly higher in males. As expected and
reported in other studies [17-19] the prevalence increased
with increasing age reaching 13.04% in patients over 70
years of age.
Table 3: Clinical features of the patients with pseudoexfoliation syndrome
Clinical Features n = (120)
Pseudoexfoliation of lens 118 (98.3%)
Flakes on Iris margin 98 (81.7%)
Poor pupil dilation 80 (66.7%)
Iris abnormalities 76 (63.3%)
Flakes on trabecular meshwork 68 (56.7%)
High intraocular pressure 48 (40%)
Zonular weakness 30 (25.0%)
Bilateral disease 120 (100%)
Occludable angles 5 (4.1%)
Table 2: Age distribution of studied population
Age range No. of subjects Percentage
45–59 years 714 38.40%
60–69 years 456 24.50%
70 and above 690 37.10%
Total 1860 100%Page 3 of 5
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the subjects with PXS had high intraocular pressure. Most
of the studies have shown prevalence of high intraocular
pressure with or without glaucoma to be in between 22%
to 30% [20-22]. It is quite possible that this high rate in
our study may be due do the design of study which was
hospital based.
We also noted that the PXS was bilateral in 100% of the
cases, which is not documented by any study, but as
shown by Prince et al and Speakman et al, the disease is
invariably bilateral pathologically [23,24]. In our study,
30 eyes of the total 240 eyes with PXS had flakes on the
iris only. The presence of flakes on the iris can be missed
easily particularly in light colored eyes, so either the
darker color of the iris makes it easily recognizable or
south Asian people truly have high prevalence of clinically
bilateral PXS [15] could be the possible explanation.
Conclusion
In conclusion we found the prevalence of PXS to be 6.45%
in a Pakistani population. This rate is similar to other
studies conducted in south Asia, however all cases were
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